A randomized trial on tamoxifen continuation during second-line hormone therapy in breast cancer

Ann N Y Acad Sci. 1993 Nov 30:698:357-61. doi: 10.1111/j.1749-6632.1993.tb17226.x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aminoglutethimide / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Hydrocortisone / analogs & derivatives
  • Hydrocortisone / therapeutic use
  • Middle Aged
  • Neoplasm Metastasis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Survival Analysis
  • Tamoxifen / therapeutic use*
  • Tamoxifen / toxicity

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tamoxifen
  • Aminoglutethimide
  • hydrocortisone acetate
  • Hydrocortisone